StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
NASDAQ BLPH opened at $0.04 on Thursday. Bellerophon Therapeutics has a 1 year low of $0.03 and a 1 year high of $0.46. The company has a fifty day moving average price of $0.04 and a 200-day moving average price of $0.05. The firm has a market cap of $428,155.00, a price-to-earnings ratio of -0.04 and a beta of 0.73.
About Bellerophon Therapeutics
Further Reading
- Five stocks we like better than Bellerophon Therapeutics
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Emerging Markets: What They Are and Why They Matter
- What does consumer price index measure?
- Recession or Not, These 3 Stocks Are Winners
- What Are Dividend Champions? How to Invest in the Champions
- Why NVIDIA Is More of a Screaming Buy Than Ever
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.